Modelli di clearance: modelli a compartimenti

Clearance directly measures drug elimination from the central compartment, which comprises plasma and highly perfused organs like kidneys and liver. It quantifies how efficiently the body removes a drug and is essential for determining appropriate dosing regimens to maintain therapeutic drug levels while minimizing potential side effects.

In the one-compartment model, clearance is calculated as the product of the terminal rate constant (λz) and total volume of distribution (Vss). This model effectively describes polar drugs like aminoglycoside antibiotics administered intravenously and readily excreted in urine, making it ideal for drugs with rapid, uniform distribution.

The flip-flop phenomenon occurs when oral drug absorption is slower than elimination. In this case, the terminal rate constant reflects absorption kinetics rather than elimination kinetics, potentially altering clearance calculations and requiring careful interpretation of pharmacokinetic parameters for accurate dosing.

The two-compartment model accurately represents pharmacokinetics of less polar drugs that distribute into poorly blood-perfused compartments. Vancomycin, a clinically important antibiotic, is effectively predicted by this model because it accounts for both central and peripheral compartment distribution, providing more accurate clearance predictions.

Distributional clearance reflects drug movement between two compartments: the central compartment including plasma and well-perfused organs, and the peripheral compartment housing less-perfused organs. Unlike total clearance, which measures elimination from the body, distributional clearance describes the rate of drug redistribution between tissue compartments.

Clearance calculations vary depending on the administration route and pharmacokinetic model used. Intravenous administration with the one-compartment model provides straightforward clearance from the product of terminal rate constant and volume of distribution, while oral administration requires consideration of absorption kinetics and potential flip-flop phenomena.

The central compartment includes plasma and highly perfused organs such as kidneys and liver. These organs receive rapid blood flow and are where most drug elimination occurs, making them critical for understanding how clearance directly measures drug removal from this compartment.